Next Article in Journal
Characterization of Composite Edible Films Based on Pectin/Alginate/Whey Protein Concentrate
Next Article in Special Issue
3D Printing of Bioceramic Scaffolds—Barriers to the Clinical Translation: From Promise to Reality, and Future Perspectives
Previous Article in Journal
Evolution of Oxygen–Ion and Proton Conductivity in Ca-Doped Ln2Zr2O7 (Ln = Sm, Gd), Located Near Pyrochlore–Fluorite Phase Boundary
Previous Article in Special Issue
Integrated Design Approaches for 3D Printed Tissue Scaffolds: Review and Outlook
Open AccessFeature PaperReview

iPSC Bioprinting: Where are We at?

1
Biomaterials Design and Tissue Engineering Lab, School of Chemistry, University of New South Wales, New South Wales 2052, Australia
2
School of Materials Science and Engineering, University of New South Wales, New South Wales 2052, Australia
*
Author to whom correspondence should be addressed.
Materials 2019, 12(15), 2453; https://doi.org/10.3390/ma12152453
Received: 7 July 2019 / Revised: 27 July 2019 / Accepted: 30 July 2019 / Published: 1 August 2019
  |  
PDF [1302 KB, uploaded 1 August 2019]
  |  

Abstract

Here, we present a concise review of current 3D bioprinting technologies applied to induced pluripotent stem cells (iPSC). iPSC have recently received a great deal of attention from the scientific and clinical communities for their unique properties, which include abundant adult cell sources, ability to indefinitely self-renew and differentiate into any tissue of the body. Bioprinting of iPSC and iPSC derived cells combined with natural or synthetic biomaterials to fabricate tissue mimicked constructs, has emerged as a technology that might revolutionize regenerative medicine and patient-specific treatment. This review covers the advantages and disadvantages of bioprinting techniques, influence of bioprinting parameters and printing condition on cell viability, and commonly used iPSC sources, and bioinks. A clear distinction is made for bioprinting techniques used for iPSC at their undifferentiated stage or when used as adult stem cells or terminally differentiated cells. This review presents state of the art data obtained from major searching engines, including Pubmed/MEDLINE, Google Scholar, and Scopus, concerning iPSC generation, undifferentiated iPSC, iPSC bioprinting, bioprinting techniques, cartilage, bone, heart, neural tissue, skin, and hepatic tissue cells derived from iPSC. View Full-Text
Keywords: 3D bioprinting; iPSC; tissue engineering; pluripotent stem cells; biofabrication 3D bioprinting; iPSC; tissue engineering; pluripotent stem cells; biofabrication
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Romanazzo, S.; Nemec, S.; Roohani, I. iPSC Bioprinting: Where are We at? Materials 2019, 12, 2453.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top